Insmed Inc. buy Wells Fargo & Company
Start price
11.06.25
/
50%
€79.50
Target price
11.06.26
€104.30
Performance (%)
113.84%
Price
17.12.25
€169.00
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Insmed Inc. has seen massive gains of 113.84%. This prediction currently runs until 11.06.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 3.681% | 3.681% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $107.00 to $119.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat